Netrin-1 administration significantly decreased the plasma levels of IL-1β, IL-6, and TNF-α, and increased plasma IL-10 levels at several specific time points after the model was induced compared to the untreated AP group (P<0.05, Figure 4). The gene discussed is IL1B; the disease is alkaline phosphatase measurement.